eIF4A inhibition: ready for primetime?

Journal article

Open access

Peer reviewed

Tyler A Cunningham, Eli Chapman and Jonathan H Schatz

Oncotarget, Vol.9(85), pp.35515-35516

2018-10-30

PMCID: PMC6238976

PMID: 30473746

Abstract

cap-dependent translation

signaling

drug discovery

experimental therapeutics

eIF4A

url

https://doi.org/10.18632/oncotarget.26268View

Published (Version of record) Open

9 Record Views

Title: eIF4A inhibition: ready for primetime?
Creators: Tyler A Cunningham - Jonathan H. Schatz: Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida, USA; Division of Hematology, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida, USA
Eli Chapman - Jonathan H. Schatz: Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida, USA; Division of Hematology, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida, USA
Jonathan H Schatz - Jonathan H. Schatz: Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida, USA; Division of Hematology, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida, USA
Publication Details: Oncotarget, Vol.9(85), pp.35515-35516
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
Language: English
Resource Type: Journal article
PMID: 30473746
PMCID: PMC6238976
Record Identifier: 991031614882302976